Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47.9M
-
Number of holders
-
192
-
Total 13F shares, excl. options
-
52.5M
-
Shares change
-
+629K
-
Total reported value, excl. options
-
$2.11B
-
Value change
-
+$26.3M
-
Number of buys
-
87
-
Number of sells
-
-90
-
Price
-
$40.20
Significant Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q4 2016
207 filings reported holding HAE - HAEMONETICS CORP - Common Stock as of Q4 2016.
HAEMONETICS CORP - Common Stock (HAE) has 192 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.5M shares
.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (5.4M shares), VANGUARD GROUP INC (4.36M shares), BlackRock Fund Advisors (4.14M shares), WELLINGTON MANAGEMENT GROUP LLP (3.42M shares), WELLS FARGO & COMPANY/MN (2.33M shares), VICTORY CAPITAL MANAGEMENT INC (2.16M shares), FULLER & THALER ASSET MANAGEMENT, INC. (2.06M shares), Neuberger Berman Group LLC (1.82M shares), DIMENSIONAL FUND ADVISORS LP (1.68M shares), and BlackRock Institutional Trust Company, N.A. (1.33M shares).
This table shows the top 192 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.